We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+18.04%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$316M
AUM Growth
+$17.7M
Cap. Flow
-$18.4M
Cap. Flow %
-5.81%
Top 10 Hldgs %
52.21%
Holding
58
New
3
Increased
32
Reduced
6
Closed
6

Sector Composition

Rank Sector Weight
1 Healthcare 82.06%
2 Communication Services 4.03%
3 Energy 1.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TECH icon
26
Bio-Techne
TECH
$11.2B
$4.67M 1.48%
154,616
+1,840
+1% +$54.6K
HSTM icon
27
HealthStream
HSTM
$819M
$4.66M 1.47%
199,243
+13,199
+7% +$314K
LHCG
28
DELISTED
LHC Group LLC
LHCG
$4.59M 1.45%
64,672
-27,245
-30% -$1.75M
VRTX icon
29
Vertex Pharmaceuticals
VRTX
$121B
$3.56M 1.13%
23,421
+302
+1% +$45.5K
BMRN icon
30
BioMarin Pharmaceuticals
BMRN
$11.6B
$2.97M 0.94%
31,902
+335
+1% +$29.6K
MGNX icon
31
MacroGenics
MGNX
$235M
$2.8M 0.89%
151,670
+90,132
+146% +$1.56M
STRM
32
DELISTED
Streamline Health Solutions
STRM
$2.59M 0.82%
117,380
-723
-0.6% -$13K
IBB icon
33
iShares Biotechnology ETF
IBB
$9.34B
$2.37M 0.75%
21,291
ENZ
34
DELISTED
Enzo Biochem, Inc.
ENZ
$2.36M 0.75%
225,616
-177,466
-44% -$1.97M
CDXS icon
35
Codexis
CDXS
$151M
$2.29M 0.73%
344,990
+70,000
+25% +$387K
IRIX icon
36
IRIDEX
IRIX
$14.3M
$2.24M 0.71%
238,795
+137,965
+137% +$1.25M
IONS icon
37
Ionis Pharmaceuticals
IONS
$8.6B
$2.15M 0.68%
42,511
+496
+1% +$26K
CELG
38
DELISTED
Celgene Corp
CELG
$2.02M 0.64%
13,856
+155
+1% +$21.1K
LMAT icon
39
LeMaitre Vascular
LMAT
$2.32B
$1.75M 0.55%
46,816
+582
+1% +$19.8K
XLVS
40
DELISTED
POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO
XLVS
$1.6M 0.51%
17,285
ALKS icon
41
Alkermes
ALKS
$8.22B
$1.53M 0.48%
30,087
+387
+1% +$20.7K
XLV icon
42
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
$1.49M 0.47%
18,241
IHI icon
43
iShares US Medical Devices ETF
IHI
$3.13B
$1.27M 0.4%
45,480
XBI icon
44
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$822K 0.26%
9,499
ABBV icon
45
AbbVie
ABBV
$443B
$370K 0.12%
4,159
SNY icon
46
Sanofi
SNY
$103B
$335K 0.11%
6,720
NVS icon
47
Novartis
NVS
$297B
$307K 0.1%
3,986
PFE icon
48
Pfizer
PFE
$143B
$306K 0.1%
9,020
JNJ icon
49
Johnson & Johnson
JNJ
$618B
$284K 0.09%
2,183
MRK icon
50
Merck
MRK
$322B
$275K 0.09%
4,500

Similar funds

First Light Asset Management's Q3 2017 Portfolio in Review

As of Q3 2017, First Light Asset Management held 58 positions worth $316M, up 5.9% from $298M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

First Light Asset Management withdrew a net $18.4M in Q3 2017, closing 6 positions and reducing 6 holdings. Its most notable exit was Akorn Inc, an estimated $24.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, up from 75% a quarter earlier, followed by Communication Services and Energy.

Against the trend, First Light Asset Management opened a new position in Globus Medical worth $5.32M.

  • First Light Asset Management's largest Q3 2017 buy was Globus Medical: 179,016 shares worth $5.32M.
  • First Light Asset Management added most to Array Biopharma Inc in Q3 2017, an estimated $8.34M increase.
  • First Light Asset Management's biggest Q3 2017 reduction was Immunomedics Inc, cutting an estimated $7.35M.
  • First Light Asset Management fully exited Akorn Inc in Q3 2017, selling an estimated $24.6M.
  • First Light Asset Management's ten largest holdings make up 52% of its $316M portfolio in Q3 2017.
  • First Light Asset Management opened 3 new positions and closed 6 in Q3 2017.
  • First Light Asset Management's portfolio value rose 5.9% quarter-over-quarter to $316M.

Based on First Light Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.